the effect of Epley therapy in patients with benign paroxysmal positional vertigo

Investigating the effect of Epley therapy in patients with benign paroxysmal positional vertigo

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240514061802N1

Enrollment

Registered

2024-07-17

Start date

2024-08-22

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

?????? ? ???? ?? ??? ??? ??????. Beinign paroxysmal vertigo

Interventions

Intervention 1: Intervention group: patients receiving epley maneuvre in addition to betahistine. Intervention 2: Control group: patients receiving betahistine alone.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Having informed consent to enter the study Not suffering from other diseases involving the vestibule Absence of pregnancy

Exclusion criteria

Exclusion criteria: Patients with central vertigo Patients with BBPV whose type of involvement is not of the posterior canal type. People with psychological diseases Having systemic diseases such as diabetes, hypertension, acute cardiovascular disease, active connective tissue disorder, chronic kidney disease, and chronic liver disease. Lack of cooperation with the researcher

Design outcomes

Primary

Measure	Time frame
Severity of BPPV symptoms. Timepoint: at the beginning of the study, on the 3rd day, 7th day and the end of the 4th week. Method of measurement: DHI questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNargess Mohammadi

Kashan University of Medical Sciences

narsis.mo1378@gmail.com031-55342020-24

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026